Accuracy of new biomarkers for assessing liver fibrosis in chronic liver disease (CLD)

被引：0
|
作者：
Lovero, R. [1 ]
Schirinzi, A. [1 ]
Todeschini, A. [2 ]
Ruta, R.
Marsico, S. [1 ]
Calamita, A. [1 ]
Genco, R. [1 ]
Varraso, L. [1 ]
Di Leo, A. [2 ]
Di Serio, F. [1 ]
机构：
[1] Univ Hosp Policlin, Clin Pathol Unit, Bari, Italy
[2] Univ Hosp Policlin, Gastroenterol Unit, Bari, Italy
来源：
CLINICA CHIMICA ACTA | 2019年 / 493卷
关键词：
D O I：
10.1016/j.cca.2019.03.787
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
T399
引用
收藏
页码：S367 / S368
页数：2
相关论文
共 50 条
  • [21] Cholinesterase: New marker of liver fibrosis in progression of type C chronic liver disease
    Yoshikumi, H
    GASTROENTEROLOGY, 2005, 128 (04) : A750 - A750
  • [22] ULTRASONOGRAPHIC (US) STUDY OF LIVER AND SPLEEN SIZE ALTERNATIONS IN CHRONIC LIVER-DISEASE (CLD)
    UNGARO, F
    PALMIERI, VO
    POZZESSERE, P
    DEPALMA, A
    PALASCIANO, G
    GASTROENTEROLOGY, 1993, 104 (04) : A1013 - A1013
  • [23] DEVELOPMENT OF LIVER ATROPHY IS A KEY EVENT IN THE NATURAL HISTORY OF EXPERIMENTAL CHRONIC LIVER DISEASE (CLD)
    Asensio, Iris
    Franco-Herrera, Carolina
    Benedicto, Ignacio
    Vazquez-Ogando, Elena
    Sierra, Johanna
    Blazquez-Lopez, Elena
    Puerto, Marta
    Salinas, Beatriz
    Cusso, Lorena
    Desco, Manuel
    Del Campo, Rosa
    Ponce-Alonso, Manuel
    Rubio, Carmen
    Ruiz, Christian
    Blanco, David
    Campbell, Jean S.
    Cubero, Francisco Javier
    Gracia-Sancho, Jordi
    Moreno, Laura
    Herrero, Raquel
    Banares, Rafael
    Vaquero, Javier
    HEPATOLOGY, 2022, 76 : S1158 - S1159
  • [24] FIBROSIS IN CHRONIC LIVER-DISEASE
    POPPER, H
    KENT, G
    CLINICS IN GASTROENTEROLOGY, 1975, 4 (02): : 315 - 332
  • [25] Enzymes of Fibrosis in Chronic Liver Disease
    Tsomidis, Ioannis
    Notas, George
    Xidakis, Costas
    Voumvouraki, Argyro
    Samonakis, Dimitrios N.
    Koulentaki, Mairi
    Kouroumalis, Elias
    BIOMEDICINES, 2022, 10 (12)
  • [26] Coagulation and fibrosis in chronic liver disease
    Calvaruso, V.
    Maimone, S.
    Gatt, A.
    Tuddenham, E.
    Thursz, M.
    Pinzani, M.
    Burroughs, A. K.
    GUT, 2008, 57 (12) : 1722 - 1727
  • [27] Cutoff Values of Liver Elasticity Measured by ARFI (Acoustic Radiation Force Impulse) Elastometry for Fibrosis Staging in Patients With Chronic Liver Disease (CLD)
    Sturm, Joerg
    Goertz, Ruediger S.
    Pfeifer, Lukas
    Wachter, David
    Neurath, Markus F.
    Strobel, Deike
    GASTROENTEROLOGY, 2012, 142 (05) : S1012 - S1012
  • [28] LIVER STIFFNESS MEASUREMENT (LSM) IS ASSOCIATED WITH ACTIVITY AND STEATOSIS GRADES PRESUMED BY BIOMARKERS (ACTITEST, STEATOTEST), INDEPENDENTLY OF FIBROSIS STAGE, IN PATIENTS WITH CHRONIC LIVER DISEASES (CLD)
    Perazzo, Hugo
    Ngo, Yen
    Lebray, Pascal
    Munteanu, Mona
    Pais, Raluca
    Moussalli, Joseph
    M'kada, Helmi
    Thabut, Dominique
    Ratziu, Vlad
    Poynard, Thierry
    HEPATOLOGY, 2011, 54 : 1219A - 1219A
  • [29] PROCOLLAGEN PEPTIDE (PP) LEVELS IN CHRONIC LIVER-DISEASE (CLD) - COMPARISON OF ANTIBODY (AB) AND FAB-RIA FOR ASSESSMENT OF LIVER FIBROSIS
    ZAUGG, PY
    WEIGAND, K
    ZIMMERMANN, A
    PREISIG, R
    HEPATOLOGY, 1985, 5 (05) : 973 - 973
  • [30] The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
    Mikolasevic, Ivana
    Domislovic, Viktor
    Krznaric-Zrnic, Irena
    Krznaric, Zeljko
    Virovic-Jukic, Lucija
    Stojsavljevic, Sanja
    Grgurevic, Ivica
    Milic, Sandra
    Vukoja, Ivan
    Puz, Petra
    Aralica, Merica
    Hauser, Goran
    MEDICINA-LITHUANIA, 2022, 58 (02):
12345